Your browser doesn't support javascript.
loading
Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia.
Tan, Yue; Shan, Lingling; Zhao, Liping; Deng, Biping; Ling, Zhuojun; Zhang, Yanlei; Peng, Shuixiu; Xu, Jinlong; Duan, Jiajia; Wang, Zelin; Yu, Xinjian; Zheng, Qinlong; Xu, Xiuwen; Tian, Zhenglong; Zhang, Yibing; Zhang, Jiecheng; Chang, Alex H; Feng, Xiaoming; Pan, Jing.
Afiliação
  • Tan Y; State Key Laboratory of Experimental Hematology, Boren Clinical Translational Center, Department of Hematology, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Shan L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Zhao L; Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Deng B; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Ling Z; Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Zhang Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
  • Peng S; Tianjin Institutes of Health Science, Tianjin, 301600, China.
  • Xu J; Cytology Laboratory, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Duan J; Department of Hematology, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Wang Z; Shanghai YaKe Biotechnology Ltd., Shanghai, 200438, China.
  • Yu X; Shanghai YaKe Biotechnology Ltd., Shanghai, 200438, China.
  • Zheng Q; Department of Hematology, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Xu X; Department of Hematology, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Tian Z; Department of Hematology, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Zhang Y; Medical Laboratory, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Zhang J; Medical Laboratory, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Chang AH; Medical Laboratory, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
  • Feng X; Gobroad Research Center, Gobroad Medical Group, Beijing, 100070, China.
  • Pan J; State Key Laboratory of Experimental Hematology, Boren Clinical Translational Center, Department of Hematology, Beijing Gobroad Boren Hospital, Beijing, 100070, China.
J Hematol Oncol ; 16(1): 34, 2023 04 05.
Article em En | MEDLINE | ID: mdl-37020231
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia-Linfoma Linfoblástico de Células T Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article